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Unit of Radiological Anatomy, Division of Anatomy and Cell Biology, United Medical and Dental
Schools, Guy’s Hospital, London, U.K.RADIOGRAPHY is used to confirm the diagnosis in
patients with knee osteoarthritis (OA), and
changes in the joint space width (JSW) are used to
monitor disease progression or the e#ectiveness of
drug treatment. Non-standardized methods for
X-raying patients’ knees results in a variable
appearance of the joint and JSW. To meet the
requirements of regulatory bodies, such as the
United States Food and Drug Administration
(FDA), standard radiographic assessment of OA
knees for therapeutic trials demand protocols that
define the radiographic and mensural procedures
and accurate and reproducible measurement of
JSW.
First Study [1]
OBJECTIVES FOR FIRST STUDY
To improve the reproducibility and accuracy of
JSW measurement as an assessment of cartilage
loss in patients with knee OA. Compared to JSW
measurement from standard radiographs of OA
knees in the standing extended view, we deter-
mined how precision and accuracy of JSW
measurement were altered by: (1) computerized
method of measurement; (2) correction for radio-
graphic magnification; (3) radiography of the
knee in the standing semi-flexed view and (4) high
definition macroradiography of the knee in the
semi-flexed view.
METHODS
Twenty-five OA knees were radiographed in the
extended view and minimum JSW measured manu-
ally. Conventional and #5 macroradiographs
were taken in the semi-flexed view. All radio-
graphs were taken twice on the same day and
repeated two weeks later. Automated computer-
ized measurement of minimum JSW was obtained
from digitally stored images of all radiographs.343RESULTS
For JSW measurements, (1) computerized was
more accurate than manual; (2) correction for
radiographic magnification improved precision
and accuracy; (3) measurements in the semi-flexed
view were more precise and accurate; (4) macro-
radiography increased measurement precision.
CONCLUSIONS
Protocols defining radiographic and mensural
procedures are essential for quality control of
knee radiography in the semi-flexed view permit-
ting accurate and reproducible measurement of
JSW. Macroradiography provides greater JSW
measurement precision.
Second Study [2].
OBJECTIVES FOR SECOND STUDY
To assess the usefulness of, and define the time
course of changes in the features of OA knees
measurable, using microfocal radiography and to
determine whether it di#ers in patients taking a
nonsteroidal antiinflammatory drug (NSAID).
METHODS
Forty-five patients with knee OA were randomly
allocated to receive either diclofenac sodium or
placebo for 18 months; 33 (17 NSAID, 16 placebo)
completed the study. Clinical and #5 high defini-
tion macroradiographic assessments of both knees
in standing semi-flexed views were carried out at
6-monthly intervals. Precise measurements were
taken of the tibial and femoral subchondral thick-
ness and osteophyte size, and of JSW across the
narrowest part of the tibio-femoral compartments.
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In all knees as a group, there was no statistically
ignificant di#erence in JSW between treatment
roups. However, changes in JSW were signifi-
antly di#erent (P<0.04, MONOVA) between
reatments in 51 knees with early disease, i.e.,
hose with initially greater than 50% JSW (22
ctive, 29 placebo), but not in 15 knees with severe
isease, i.e., initially less than 50% JSW (10 active,
ve placebo) (Fig. 1). During the study, osteophyte
ize in all knees and in those with >50% JSW
ncreased significantly (P<0.016; P<0.008) in the
lacebo but remained unchanged in the treatment
roup. No significant changes were detected in
ubchondral cortical thickness.
CONCLUSIONS
Using microfocal radiography the time course of
hanges in JSW and osteophyte size of knees with
arly, but not late OA, was found to di#er in both
attern and magnitude in patients receiving a
SAID. Using reproducible radiographic andmensural procedures it is possible to detect signifi-
cant changes in minimum JSW within 18 months
and less [2]. Based upon our data it is possible to
determine the total number of knees (i.e., both
groups) that would be needed for therapeutic
studies of 2 years duration. To detect a significant
di#erence in JSW, for a drug with a 30% thera-
peutic e#ect and at a 90% power, we would need
about 1100 knees using the conventional method;
or 400 using standard radiography with a semi-
flexed knee or 250 knees or 125 patients using
microfocal radiography.
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therapy. J Rheumatol 1995;22:937–43.FIG. 1. Graphs of the mean (SD) change in joint space width at each 6-month visit in knees with (left) early
osteoarthritis (with a joint space width greater than 2.3 mm, i.e., <50% of that in normal healthy knees), and (right)
late stage osteoarthritis (joint space width <50% of that in normal healthy knees) in patients receiving either
diclofenac (;) or placebo (/).
